Patent directory · USPTO A61K / A61P
Patents matching “pd-”
81 pharma patents match "pd-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 81 pharmaceutical patents matching "pd-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11976128
Human PD-L2 antibodies and methods of use therefor
granted -
US 11939581
Methods and compositions for targeting PD-L1
granted -
US 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted -
US 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted -
CA 3259391
POLYTHÉRAPIE ANTI-GARP-TGF-β1/PD-1
granted -
US 11786553
Chimeric cytokine receptors bearing a PD-1 ectodomain
granted -
US 11760761
Methods and compositions for targeting PD-L1
granted -
US 11760764
Methods and compositions for targeting PD-L1
granted -
CA 3245150
COMBINAISONS AVEC UN ANTICORPS ANTI-CD39 HUMAIN, UN ANTICORPS ANTI-PD-1 HUMAIN ET UNE CHIMIOTHÉRAPIE CONTRE LE CANCER GASTRIQUE
granted -
US 11746152
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
granted -
US 11718679
CD137 antibodies and PD-1 antagonists and uses thereof
granted -
US 11713353
Single-domain antibodies and variants thereof against PD-1
granted -
US 11685918
Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11673954
Single-domain antibodies and variants thereof against PD-L1
granted -
US 11660352
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
granted -
US 11661455
Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
granted -
US 11566076
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
granted -
US 11542312
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 11525002
Human PD-L1 antibodies and methods of use therefor
granted -
US 11505600
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
US 11498966
PD-1 and PD-L1 binding agents
granted -
US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted -
US 11464795
Saponin compound targeting PD-1 and application thereof
granted